USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.56M | -21.38M | 7.52M | -1.78M | -6.52M |
| Total Depreciation and Amortization | 9.67M | 9.17M | 9.79M | 10.29M | 9.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.64M | 22.42M | 6.32M | 6.27M | 5.92M |
| Change in Net Operating Assets | 4.22M | 13.11M | -13.86M | -18.17M | -10.93M |
| Cash from Operations | 11.97M | 23.32M | 9.76M | -3.39M | -1.96M |
| Capital Expenditure | -3.52M | -3.16M | -2.65M | -2.80M | -3.20M |
| Sale of Property, Plant, and Equipment | 3.00K | 15.00K | 48.00K | 3.91M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -917.00K | -- | 0.00 | 0.00 |
| Cash from Investing | -3.52M | -4.06M | -2.60M | 1.11M | -3.20M |
| Total Debt Issued | 0.00 | 5.00M | 4.00M | 16.00M | 0.00 |
| Total Debt Repaid | 0.00 | -19.00M | -4.00M | -2.00M | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -92.00K | -26.00K | -2.27M | -56.00K | -100.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -1.38M | -491.00K | -879.00K |
| Cash from Financing | -92.00K | -14.03M | -3.64M | 13.45M | -979.00K |
| Foreign Exchange rate Adjustments | 2.04M | 615.00K | 896.00K | 1.91M | 165.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.39M | 5.85M | 4.42M | 13.09M | -5.97M |